Page last updated: 2024-08-23

lovastatin and Cortical Lewy Body Disease

lovastatin has been researched along with Cortical Lewy Body Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adame, A; Kelly, J; Koob, AO; Mante, M; Masliah, E; Paulsson, JF; Rockenstein, E; Ubhi, K	1

Other Studies

1 other study(ies) available for lovastatin and Cortical Lewy Body Disease

Article	Year
Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies. Experimental neurology, 2010, Volume: 221, Issue:2 Topics: alpha-Synuclein; Analysis of Variance; Animals; Brain; Cholesterol; Dendrites; Disease Models, Animal; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lewy Body Disease; Lovastatin; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Neurons; Oxidation-Reduction; Parkinson Disease; Platelet-Derived Growth Factor; Thy-1 Antigens	2010

Article

Year

Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies.

Experimental neurology, 2010, Volume: 221, Issue:2

Topics: alpha-Synuclein; Analysis of Variance; Animals; Brain; Cholesterol; Dendrites; Disease Models, Animal; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lewy Body Disease; Lovastatin; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Neurons; Oxidation-Reduction; Parkinson Disease; Platelet-Derived Growth Factor; Thy-1 Antigens

2010